Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
Nitin Patel, J. San‐Miguel, Phoebe Joy Ho, Surbhi Sidana et al.
Citations
2 citations
Journal
The Lancet Oncology
Topics
Multiple Myeloma Research and Treatments
Field-Weighted Citation Impact (FWCI)
70.83
article
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
Nitin Patel, J. San‐Miguel, Phoebe Joy Ho, Surbhi Sidana, Erika Florendo, Nikoletta K. Lendvai, Vicki Plaks, Mythili Koneru, Martinez-Lopez Joaquin, Arnab Ghosh, Diana Chen, Tzu-min Yeh, Albert Oriol, Xavier P Leleu, Binod Dhakal, Cyrille Touzeau, Carolina Lonardi, Ana Slaughter, Yael Chava Cohen, Rakesh Popat, Jordan Mark Schecter, Martin Vogel, Simon James Harrison, Paolo Corradini, Nina Benachour, María-Victoria Mateos, Lionel Karlin, Niels WCJ van de Donk, Hermann Einsele, Katherine Li, Quanlin Li
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet OncologyVol. 27(2)
Institutions
Centre National de la Recherche Scientifique (FR), Johnson & Johnson (United States) (US), University College London Hospitals NHS Foundation Trust (GB), Inserm (FR), Universidad de Salamanca (ES), Medical College of Wisconsin (US), Royal Prince Alfred Hospital (AU), Tel Aviv Sourasky Medical Center (IL), Peter MacCallum Cancer Centre (AU), Université de Poitiers (FR), Johnson & Johnson (Switzerland) (CH), 490 BioTech (United States) (US), Universitäts-Kinderklinik Würzburg (DE), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR), Centre Hospitalier Universitaire de Poitiers (FR), Hôpital Lyon Sud (FR), Johnson & Johnson (Germany) (DE), Johnson Electric (China) (CN), Instituto de Investigación Biomédica de Salamanca (ES), Clinica Universidad de Navarra (ES), Johnson & Johnson (Israel) (IL), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), Centro de Investigación del Cáncer (ES), Amsterdam University Medical Centers (NL), Hospital Universitari Germans Trias i Pujol (ES), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), University College London (GB), Vrije Universiteit Amsterdam (NL), Stanford University (US), Nantes Université (FR)